Correlation Between Eliem Therapeutics and Cyclacel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Cyclacel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Cyclacel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Cyclacel Pharmaceuticals, you can compare the effects of market volatilities on Eliem Therapeutics and Cyclacel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Cyclacel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Cyclacel Pharmaceuticals.
Diversification Opportunities for Eliem Therapeutics and Cyclacel Pharmaceuticals
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Eliem and Cyclacel is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Cyclacel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclacel Pharmaceuticals and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Cyclacel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclacel Pharmaceuticals has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Cyclacel Pharmaceuticals go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Cyclacel Pharmaceuticals
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 0.44 times more return on investment than Cyclacel Pharmaceuticals. However, Eliem Therapeutics is 2.28 times less risky than Cyclacel Pharmaceuticals. It trades about -0.28 of its potential returns per unit of risk. Cyclacel Pharmaceuticals is currently generating about -0.22 per unit of risk. If you would invest 509.00 in Eliem Therapeutics on August 29, 2024 and sell it today you would lose (205.00) from holding Eliem Therapeutics or give up 40.28% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Eliem Therapeutics vs. Cyclacel Pharmaceuticals
Performance |
| Timeline |
| Eliem Therapeutics |
| Cyclacel Pharmaceuticals |
Eliem Therapeutics and Cyclacel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Cyclacel Pharmaceuticals
The main advantage of trading using opposite Eliem Therapeutics and Cyclacel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Cyclacel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclacel Pharmaceuticals will offset losses from the drop in Cyclacel Pharmaceuticals' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Cyclacel Pharmaceuticals vs. Eliem Therapeutics | Cyclacel Pharmaceuticals vs. Ikena Oncology | Cyclacel Pharmaceuticals vs. Ovid Therapeutics | Cyclacel Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges |